NASDAQ:INSM

Insmed Stock Insider Trading

etoro logo Buy INSM
*Your capital is at risk
$102.15
+3.55 (+3.60%)
At Close: Jun 23, 2026

Insmed Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -95.45. In total, the insiders bought 441.68K and sold 321.43K INSM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-95.45
Buy 441.68K shares
Sell 321.43K shares
46% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jan 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -95.45.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 08, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 6 515
Value: $612.6K
Jun 05, 2026
Sell
Common Stock
S-Sale
Flammer Martina M.d.
Chief Medical Officer
Officer 1 858
Value: $192.8K
Jun 03, 2026
Sell
Common Stock
S-Sale
Adsett Roger
Chief Operating Officer
C-Suite Officer 2 370
Value: $242.4K
Jun 03, 2026
Sell
Common Stock
S-Sale
Bonstein Sara
Chief Financial Officer
C-Suite Officer 2 404
Value: $245.9K
Jun 03, 2026
Sell
Common Stock
S-Sale
Smith Michael Alexander
Chief Legal Officer
Officer 2 159
Value: $220.8K
Jun 03, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 7 605
Value: $777.8K
Jun 03, 2026
Sell
Common Stock
S-Sale
Flammer Martina M.d.
Chief Medical Officer
Officer 2 566
Value: $262.4K
May 22, 2026
Sell
Common Stock
S-Sale
Smith Michael Alexander
Chief Legal Officer
Officer 6 149
Value: $667.0K
May 18, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
May 18, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 7 975
Value: $853.1K
May 18, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 11 836
Value: $1.26M
May 18, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 5 753
Value: $605.9K
May 18, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 6 259
Value: $190.6K
May 18, 2026
Buy
Common Stock
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K
May 18, 2026
Buy
Stock Option (right to buy)
M-Exempt
Lewis William
Chair And CEO
CEO / President 4 440
Value: $76.2K
May 14, 2026
Sell
Common Stock
S-Sale
Flammer Martina M.d.
Chief Medical Officer
Officer 10 479
Value: $1.23M
May 13, 2026
Buy
Common Stock
A-Award
Lee Leo
Director
Director 3 305
Value: $390.0K
May 13, 2026
Buy
Common Stock
A-Award
Desjardins Clarissa
Director
Director 3 305
Value: $390.0K
May 13, 2026
Buy
Common Stock
A-Award
Brennan David R
Director
Director 3 305
Value: $390.0K
May 13, 2026
Buy
Common Stock
A-Award
Sharoky Melvin Md
Director
Director 3 305
Value: $390.0K
May 13, 2026
Sell
Common Stock
S-Sale
Smith Michael Alexander
Chief Legal Officer
Officer 4 109
Value: $477.4K
May 13, 2026
Sell
Common Stock
S-Sale
Flammer Martina M.d.
Chief Medical Officer
Officer 3 384
Value: $393.2K
May 13, 2026
Sell
Common Stock
S-Sale
Flammer Martina M.d.
Chief Medical Officer
Officer 4 470
Value: $504.0K
May 13, 2026
Sell
Common Stock
S-Sale
Lewis William
Chair And CEO
CEO / President 13 283
Value: $1.54M
May 13, 2026
Sell
Common Stock
S-Sale
Adsett Roger
Chief Operating Officer
C-Suite Officer 5 837
Value: $678.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT INSMED
Insmed
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
EAT
$140.46
16.94% Jun 05
E
ETD
$20.67
4.79% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE